CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)N3CCN(c4ccccc4)CC3)cc21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?